Carbon Dot‐Linked Hydrogel for TAMs Transform: Spatiotemporal Manipulation to Reshape Tumor Microenvironment

L Lingyun Li (State Key Laboratory of Synergistic Chem-Bio Synthesis, School of Chemistry and Chemical Engineering, New Cornerstone Science Laboratory, Frontiers Science Center for Transformative Molecules, Zhang Jiang Institute for Advanced Study and National Center for Translational Medicine, Shanghai Jiao Tong University) J Jun Wu X Xue Wu Z Zhenjian Li (Institute of Applied Physics and Materials Engineering Joint Key Laboratory of the Ministry of Education University of Macau Taipa Macau SAR P. R. China) X Xianming Zhang Z Zekun Yan (Institute of Applied Physics and Materials Engineering Joint Key Laboratory of the Ministry of Education University of Macau Taipa Macau SAR P. R. China) Y Yingqi Liang (School of Chemical Engineering and Technology, Sun Yat-sen University 1 , Zhuhai 519082,) C Caishi Huang (Faculty of Health Science University of Macau Taipa Macau SAR P. R. China) S Songnan Qu

Abstract

Abstract As one of the most crucial immune cells in the tumor microenvironment (TME), regulating tumor‐associated macrophages (TAMs) is vital for enhancing antitumor immunity. Here, an injectable carbon dots (CDs)‐linked egg white hydrogel was developed, termed TAMs Transform Factory (TTF‐L‐C), to spatiotemporally manipulate TAMs. The fabricated CDs significantly promoted macrophage migration. Notably, TTF‐L‐C achieved macrophage spatial enrichment through CDs‐induced directional recruitment with molecular Ctnnd1 upregulation. Subsequently, the recruited macrophages were locoregionally reprogrammed within TTF‐L‐C, as well as blocking the upregulated PD‐L1. Finally, through multi‐stage regulation at spatial, cellular, and molecular levels, TTF‐L‐C released immune‐activated M1 macrophages to the tumor site as it degraded. Moreover, TTF‐L‐C promoted dendritic cell (DCs) maturation and further boosted T cell activation, thereby reshaping the tumor‐suppressive TME. Through peritumoral injection, TTF‐L‐C enhanced tumor immunotherapy in both subcutaneous and recurrent 4T1 tumor models with satisfactory biosafety. Therefore, TTF‐L‐C is proposed to become a safe and powerful platform for various biomedical applications.

Article Details

Volume / Issue Vol. 37, Issue 20
Published May 01, 2025
ISSN 0935-9648
Publisher Unknown Publisher

Journal Info

Advanced Materials

Unknown Publisher

ISSN: 0935-9648 Physical Sciences

Authors (9)

L

Lingyun Li

State Key Laboratory of Synergistic Chem-Bio Synthesis, School of Chemistry and Chemical Engineering, New Cornerstone Science Laboratory, Frontiers Science Center for Transformative Molecules, Zhang Jiang Institute for Advanced Study and National Center for Translational Medicine, Shanghai Jiao Tong University

J

Jun Wu

X

Xue Wu

Z

Zhenjian Li

Institute of Applied Physics and Materials Engineering Joint Key Laboratory of the Ministry of Education University of Macau Taipa Macau SAR P. R. China

X

Xianming Zhang

Z

Zekun Yan

Institute of Applied Physics and Materials Engineering Joint Key Laboratory of the Ministry of Education University of Macau Taipa Macau SAR P. R. China

Y

Yingqi Liang

School of Chemical Engineering and Technology, Sun Yat-sen University 1 , Zhuhai 519082,

C

Caishi Huang

Faculty of Health Science University of Macau Taipa Macau SAR P. R. China

S

Songnan Qu